NTU student Raphaella Gautama has a rare condition that causes muscle and tissue to gradually change into bone. Read more at ...

To better understand flare-up mechanisms, the research team first attempted to identify molecules responsible for triggering the MSC proliferation in FOP patients. For this, they tested a panel of ...

There is variability in FOP manifestation; flare-ups can occur in different parts of the body, leading to referrals to various medical specialties. To improve medical education, and to raise ...

Symptoms of FOP usually start during childhood, with some of the earliest affected areas normally being the neck, back, chest, arms and legs. Patients may also experience "flare-ups," which are ...

There is variability in FOP manifestation; flare-ups can occur in different parts of the body, leading to referrals to various medical specialties. To improve medical education, and to raise ...

The regulator has cleared the oral selective retinoic-acid receptor gamma (RARγ) agonist for both chronic use and flare-ups in FOP, a genetic disorder in which tendons and ligaments gradually ...

The U.S. Food and Drug Administration (FDA) has granted andecaliximab a Rare Pediatric Disease Designation (RPDD) for the treatment of FOP. An RPDD designation is granted to potential treatments for ...